华仁药业 (300110.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(华仁药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 302,160,742.94364,758,064.86406,703,155.73420,328,604.80386,881,442.49425,804,491.59403,241,817.91
 营业收入(元) 302,160,742.94364,758,064.86406,703,155.73420,328,604.80386,881,442.49425,804,491.59403,241,817.91
二、营业总成本(元) 279,734,032.21342,958,878.75340,912,234.64372,518,793.24311,342,204.38371,234,743.26349,719,742.04
 营业成本(元) 205,865,495.17244,472,417.30235,725,086.42254,300,029.59203,477,003.23244,194,101.41235,230,844.32
 研发费用(元) 14,707,194.1716,710,436.2518,160,646.7725,255,119.1714,868,293.3113,697,747.0614,860,243.45
 营业税金及附加(元) 4,994,733.755,494,207.246,240,526.916,424,943.165,564,273.005,646,985.476,924,890.03
 销售费用(元) 18,242,469.9836,173,790.7542,875,979.1150,900,772.9246,799,187.0061,248,489.2355,041,516.89
 管理费用(元) 23,197,013.3325,562,975.5221,898,219.8623,127,759.6224,050,863.4526,984,284.5922,877,441.69
 财务费用(元) 12,727,125.8214,545,051.6816,011,775.5712,510,168.7816,582,584.3919,463,135.5014,784,805.66
  其中:利息费用(元) 13,148,623.0012,287,357.0115,255,129.8314,126,781.7915,167,681.8017,452,020.4914,768,332.67
  其中:利息收入(元) 105,597.31669,134.92-249,437.501,413,274.00182,077.86318,109.72244,841.21
 资产减值损失(元) ---1,451,480.86-9,834,021.88901,579.40--
 信用减值损失(元) 4,668,276.963,260,781.41-8,842,393.3825,184,992.77-12,519,864.19-17,292,124.73-7,798,196.64
三、其他经营收益
 加:投资收益(元) ---542,207.99---
 资产处置收益(元) ----239,546.89-7,777.85--
 其他收益(元) 1,434,620.754,248,319.293,183,239.657,731,807.712,400,277.89112,874.28955,678.09
四、营业利润(元) 28,529,608.4429,670,719.7658,680,286.5071,195,251.2666,313,453.3641,756,061.3646,679,557.32
 加:营业外收入(元) 340,462.32224,529.2417,202.923,729,338.44382,392.192,646,646.10136,317.71
 减:营业外支出(元) 1,591,732.69461,862.67998,477.741,624,008.73199,509.14436,709.7464,120.09
五、利润总额(元) 27,278,338.0729,433,386.3357,699,011.6873,300,580.9766,496,336.4143,965,997.7246,751,754.94
 减:所得税费用(元) 3,521,861.335,096,923.255,320,827.3420,526,836.3310,283,528.891,398,475.234,881,094.44
六、净利润(元) 23,756,476.7424,336,463.0852,378,184.3452,773,744.6456,212,807.5242,567,522.4941,870,660.50
(一)按经营持续性分类
  持续经营净利润(元) 23,756,476.7424,336,463.0852,378,184.3452,773,744.6456,212,807.5242,567,522.4941,870,660.50
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 22,317,908.6322,390,128.9250,822,916.8850,979,442.7954,801,702.7041,178,982.4841,102,886.41
  少数股东损益(元) 1,438,568.111,946,334.161,555,267.461,794,301.851,411,104.821,388,540.01767,774.09
 扣除非经常性损益后的净利润(元) 22,167,480.9319,031,296.9148,779,071.0140,482,791.4351,363,296.7334,546,463.0840,207,830.47
七、每股收益
 一、基本每股收益(元) 0.020.020.040.040.050.030.03
 二、稀释每股收益(元) 0.020.020.040.040.050.030.03
九、综合收益总额(元) 23,756,476.7424,336,463.0852,378,184.3452,773,744.6456,212,807.5242,567,522.4941,870,660.50
 归属于母公司所有者的综合收益总额(元) 22,317,908.6322,390,128.9250,822,916.8850,979,442.7954,801,702.7041,178,982.4841,102,886.41
 归属于少数股东的综合收益总额(元) 1,438,568.111,946,334.161,555,267.461,794,301.851,411,104.821,388,540.01767,774.09
公告日期 2024-10-292024-08-302024-04-252024-04-252023-10-252023-08-262023-04-20
审计意见(境内) 标准无保留意见

前瞻产业研究院